Shaun Mehr, Author at ADC Review

20 POSTS 0 COMMENTS

https://sunvalleycommunication.com

Shaun Mehr is the Associate Publisher of ADC Review, Journal of Antibody-drug Conjugates and Onco'Zine, The International Journal of Oncology. He has over 20 years experience in custom publishing, advertising sales and media consulting for Fortune 100 companies including: Dell Technologies, Oracle and HP. He also has extensive association publishing experience, including representing the world's largest association of engineers, the IEEE.

Shaun Mehr

Next Generation Immunotherapies

MilliporeSigma Acquires Data Management and Analysis Platform for Biopharma Real-Time Process...

Conference Update – 10th Annual World ADC San Diego 2019

WuXi Biologics Expands Integrated Biologics Conjugation Solution Center

15th ICML ADC Presentation Overview

World ADC Highlights

Webinar: Predicting And Lowering The Cost Of Antibody Drug Conjugates

Mersana Presents Interim Phase 1 Data for XMT-1536 at the 2019...

Three U.S. Companies Awarded MilliporeSigma’s Advance Biotech Grant

ASCO 2019 ADC Presentation Guide

Latest

Priority Review for Supplemental Biologics License Application of Enfortumab Vedotin + Pembrolizumab in First-Line...

Creating A Strong ADC Pipeline: AbbVie Agrees to Acquires ImmunoGen for $10.1 Billion

Phase 2 LUMINOSITY Study Shows Positive Results for Telisotuzumab Vedotin in for Patients with...

Peer Review

Validation of ADC Platform for Protein Concentration and the Drug-Antibody Ratio (DAR) using Variable...

Unlocking the Potential of Antibody-drug Conjugates

AJICAP Second-generation: Realizing Versatility and Robustness through Fc-Affinity Guided Chemical Conjugation Technology